|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A61P 35/00 | (2006.01) | ||
| A61P 37/00 | (2006.01) | ||
| A61K 39/00 | (2006.01) |
| (11) | Number of the document | 2949670 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15168902.3 |
| Date of filing the European patent application | 2010-12-07 | |
| (97) | Date of publication of the European application | 2015-12-02 |
| (45) | Date of publication and mention of the grant of the patent | 2019-02-27 |
| (46) | Date of publication of the claims translation | 2019-05-27 |
| (30) | Number | Date | Country code |
| 09015310 | 2009-12-10 | EP | |
| 10173407 | 2010-08-19 | EP |
| (72) |
Dimoudis, Nikolaos, DE
Kaluza, Klaus, DE
Seeber, Stefan, DE
Fertig, Georg, DE
Lanzendoerfer, Martin, DE
Ries, Carola, DE
Thomas, Marlene, DE
Fidler, Alexander, DE
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Antikūnai, prisijungiantys pirmiausiai prie žmogaus CSF-1 ekstraląstelinio domeno 4, ir jų naudojimo būdai |
| ANTIBODIES BINDING PREFERENTIALLY HUMAN CSF1R EXTRACELLULAR DOMAIN 4 AND THEIR USE |
| Payment date | Validity (years) | Amount | |
| 2024-11-21 | 15 | 289.00 EUR |
| 2025-12-07 |